Resistant social anxiety disorder response to Escitalopram

BACKGROUND: Social Anxiety Disorder (SAD) is a common disorder and its high prevalence and lifelong chronicity are such that it represents a substantial public health problem. The observation that serotonergic agents appear to be effective for its treatment suggests that patients may have abnormal s...

Descripción completa

Detalles Bibliográficos
Autores principales: Pallanti, Stefano, Quercioli, Leonardo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Study protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1769378/
https://www.ncbi.nlm.nih.gov/pubmed/17166264
http://dx.doi.org/10.1186/1745-0179-2-35

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1769378/
https://www.ncbi.nlm.nih.gov/pubmed/17166264
http://dx.doi.org/10.1186/1745-0179-2-35

Ejemplares similares